• Explore /
  • Poster
  • / A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).

A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).

Abstract Poster

Authors

null

Marit Ahrens

Medical Clinic II, University Hospital, Frankfurt Am Main, Germany

Marit Ahrens , Bernard Escudier , John B. A. G. Haanen , Ekaterini Boleti , Marine Gross Goupil , Marc-Oliver Grimm , Sylvie Negrier , Philippe Barthelemy , Gwenaelle Gravis , Philipp Ivanyi , Jens Bedke , Daniel Castellano , Andrej Panic , Begona Mellado , Pablo Maroto-Rey , Sylvie Rottey , Stefanie Zschaebitz , Dorothee Deckbar , Arndt Hartmann , Lothar Bergmann

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03075423

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS4597)

DOI

10.1200/JCO.2021.39.15_suppl.TPS4597

Abstract #

TPS4597

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Marit Ahrens

First Author: Audreylie Lemelin

First Author: Joseph Vento

First Author: Yu Fujiwara